STD SCREENING
Table I-5-1. Initial Prenatal Labs for STDs
Chlamydia/Gonorrhea
(GC)
Screening DNA probes
Hepatitis B virus Screening Hepatitis B surface antigen (HBsAg)
Syphilis Screening VDRL/rapid plasma reagin (RPR)
Definitive Microhemagglutination assay/fluorescent treponema antibody
absorption (MHA/FTA)
HIV Screening Enzyme-linked, immunosorbent assay (ELISA)
Definitive Western Blot
Cervical cultures: Screening cultures for chlamydia and gonorrhea will
identify whether the fetus is at risk from delivery through an infected birth
canal.
Syphilis: Nonspecific screening tests (venereal disease research laboratory
[VDRL] or rapid plasma reagin [RPR]) are performed on all pregnant
women. Positive screening tests must be followed up with treponema-specific
tests (microhemagglutination assay for antibodies to T. pallidum [MHA-TP]
or fluorescent treponema antibody absorption [FTA]). Treatment of
syphilis in pregnancy requires penicillin to ensure adequate fetal treatment.
Hepatitis B: Maternal hepatitis B surface antigen (HBsAg) screening assesses
if the mother could have active hepatitis, as well as if she could transmit HBV
to her newborn at the time of delivery.
http://ebookobgyne.net